<DOC>
	<DOC>NCT01241526</DOC>
	<brief_summary>The goal of the study is to evaluate a Home-Based Disease Management program specifically developed for patients with Gold III/IV COPD. By improving disease knowledge, awareness of significant clinical deterioration and self-management skills for patients, this Home-Based COPD Management Program is expected to reduce the severity of exacerbations, the need for emergency hospitalisations, thus demonstrating the efficacy and the cost effectiveness of this intervention.</brief_summary>
	<brief_title>The COPD Patient Management European Trial (COMET)</brief_title>
	<detailed_description>Primary objective: To evaluate a strategy of Chronic Obstructive Pulmonary Disease (COPD) management to reduce the number of hospital days in patients with severe Gold III/IV COPD: a Home-Based COPD Management Program versus usual patient education and follow-up. Secondary objectives: - To assess the clinical outcome and the health-related quality of life, - To assess safety, - To evaluate medico-economic impact.</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Confirmed Gold III/IV COPD Current or exsmoker with a smoking history â‰¥ 10 packyears At least one COPD exacerbation leading to hospitalization in the year before selection. LTOT for another reason than COPD Severe concomitant disorder associated with a limited probability of survival (&lt; 6 months) Tracheostomy Long term oral corticosteroids therapy</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>COMET</keyword>
	<keyword>Disease management</keyword>
</DOC>